Email
Password
Remember meForgot password?
Log in with Facebook Log in with Twitter
Connect your Digital Journal account with Facebook or Twitter to use this feature.
Press Release

Shire Announces Two Additional Scholarships As Part Of Its ADHD Scholarship Program

>PRWEB.COM Newswire

Philadelphia, PA (PRWEB) March 05, 2014

Shire is pleased to announce that it has added two scholarships to the 2014 Michael Yasick ADHD Scholarship by Shire. The scholarship program is named in memory of Michael Yasick, a senior executive at Shire whose vision made the ADHD Scholarship Program possible. These scholarships will be awarded to individuals in the United States diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) who are 25 years of age and older and attending or returning to school.

The Michael Yasick ADHD Scholarship by Shire includes a $2,000 monetary award and offers a prepaid year of ADHD coaching services. The ADHD coaching services are provided by the Edge Foundation and are intended to assist the scholarship recipient with higher education. Fifty-two one-time scholarships will be awarded in June 2014. The deadline to apply is March 19, 2014. Applicants must be accepted by or will be enrolled in an undergraduate program at an accredited college, university, trade school, technical school, or vocational school. For additional information regarding eligibility requirements, the scholarship application process, and more, visit http://www.ShireADHDscholarship.com.

“At Shire, we understand that ADHD affects not only children and adolescents, but also adults, some of whom may be non-traditional students attending or returning to college. We want to recognize the particular needs of these students by offering two additional scholarships along with the year of coaching by the Edge Foundation. To accomplish this, Shire will focus on applicants 25 years of age and older for these additional scholarships,” said Perry Sternberg, Head of Shire’s Neuroscience Business Unit.

Mike Yasick, for whom the scholarship program is now named, was inspired by the thousands of high school seniors, college students, and adults going on to higher education who suffer from ADHD. He envisioned the scholarship as a way to recognize the brave individuals who work hard to overcome the challenges of this condition, and help them continue their educational pursuits.

The panel of distinguished judges who will be reviewing the scholarship applications consists of:

Carol Caruso, Executive Director, National Alliance on Mental Illness, PA Montgomery County
Evelyn Polk Green, President, the Attention Deficit Disorder Association
Lawrence Gross, Member of the Board of Directors, Group for the Advancement of Psychiatry
Barbara S. Hawkins, Retired educator and CHADD board member
James Nininger, Clinical Associate Professor of Psychiatry, Cornell University Medical College
Sheri Stump, Senior Director, Consumer Marketing ADHD, Shire

Since the start of the program in 2011, Shire has announced 191 national scholarship award recipients and 12 employee scholarship award recipients. To see a full list of scholarship recipients, visit http://www.ShireADHDscholarship.com.

The Edge Foundation is a Seattle-based non-profit organization that offers support for students with ADHD. The Edge Foundation provides access to qualified, professional coaches for students with ADHD as part of their multimodal treatment program. For more information about the Edge Foundation, visit http://www.edgefoundation.org.

The Michael Yasick ADHD Scholarship by Shire is part of Shire’s patient-centric approach that provides support to ADHD patients and their caregivers. For further information, please contact:

Media - Gwen Fisher (gfisher(at)shire(dot)com) 1-484-595-9836

Shire Pharmaceuticals

Charlotte Zang (czang(at)benchworks(dot)com) 1-410-810-8862

Benchworks

NOTES TO EDITORS

Shire enables people with life-altering conditions to lead better lives.

Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.

We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal and Internal Medicine, and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas. http://www.shire.com

Read the full story at http://www.prweb.com/releases/2014/03/prweb11639191.htm